𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ligand migration in human indoleamine-2,3 dioxygenase

✍ Scribed by Karin Nienhaus; Elena Nickel; Changyuan Lu; Syun-Ru Yeh; G. Ulrich Nienhaus


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
430 KB
Volume
63
Category
Article
ISSN
1521-6543

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Human indoleamine 2,3‐dioxygenase (hIDO), a monomeric heme enzyme, catalyzes the oxidative degradation of L‐tryptophan (L‐Trp) and other indoleamine derivatives. Its activity follows typical Michaelis–Menten behavior only for L‐Trp concentrations up to 50 μM; a further increase in the concentration of L‐Trp causes a decrease in the activity. This substrate inhibition of hIDO is a result of the binding of a second L‐Trp molecule in an inhibitory substrate binding site of the enzyme. The molecular details of the reaction and the inhibition are not yet known. In the following, we summarize the present knowledge about this heme enzyme. © 2011 IUBMB IUBMB Life, 63(3): 153–159, 2011


📜 SIMILAR VOLUMES


Indoleamine 2,3-dioxygenase in intestina
✍ Bobby J. Cherayil 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Indoleamine 2,3-dioxygenase (IDO) is a tryptophan catabolizing enzyme that has a number of immunoregulatory effects. It is expressed at high levels in the gastrointestinal tract, particularly in the small intestine, and has been implicated in the control of intestinal inflammation. However, its prec

Inhibition of indoleamine 2,3-dioxygenas
✍ Colin R. MacKenzie; Ralf Langen; Osamu Takikawa; Walter Däubener 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Induction of indoleamine 2,3-dioxygenase (IDO) by IFN-+ results in growth inhibition of Toxoplasma and Chlamydia spp. as well as tumor cells. This is caused by the degradation, and therefore depletion, of L-tryptophan necessary for cell protein synthesis. Human macrophages stimulated with IFN-+ expr

Suppression of islet allogeneic immune r
✍ Reza B. Jalili; Gina R. Rayat; Ray V. Rajotte; Aziz Ghahary 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

## Abstract Success of transplantation of pancreatic islets which is a promising way for restoring efficient insulin regulation in type 1 diabetes depends on lifelong use of immunosuppressive drugs. To eliminate the use of systemic immunosuppressive drugs for islet transplantation, we examined the

Indoleamine 2,3-dioxygenase contributes
✍ Maria Friberg; Ronald Jennings; Marwan Alsarraj; Sophie Dessureault; Alan Cantor 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 447 KB

The priming of an appropriate anti-tumor T cell response rarely results in the rejection of established tumors. The characteristics of tumors that allow them to evade a T cell-mediated rejection are unknown for many tumors. We report on evidence that the expression of the immunosuppressive enzyme, i

High expression of IMPACT protein promot
✍ Darya Habibi; Reza B. Jalili; Farshad Forouzandeh; Christopher J. Ong; Aziz Ghah 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB

## Abstract Indoleamine 2,3‐dioxygenase (IDO), a tryptophan degrading enzyme, is a potent immunomodulatory factor. IDO expression in fibroblasts selectively induces apoptosis in immune cells but not in primary skin cells. However, the mechanism(s) of this selective effect of IDO‐induced low tryptop

Inhibition of allogeneic T-cell response
✍ Naoko Funeshima; Masayuki Fujino; Yusuke Kitazawa; Yuko Hara; Yoshiaki Hara; Kou 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

## Abstract ## Background Indoleamine 2,3‐dioxygenase (IDO) is an enzyme involved in the catabolism of tryptophan and has been shown to prevent rejection of the fetus during pregnancy by inhibiting alloreactive T cells. ## Methods In this study we investigated dendritic cells (DCs) that are tran